Product
BMS-986369
3 clinical trials
3 indications
Indication
T-cell LymphomasIndication
Healthy ParticipantsIndication
Healthy VolunteerClinical trial
A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics, and Efficacy of BMS-986369 in Participants With Relapsed or Refractory T-cell Lymphomas in JapanStatus: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
A Phase 1, Single-center, Open-label Study to Evaluate the Metabolism and Excretion of [14C] BMS-986369 in Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2022-12-27
Clinical trial
A Phase 1, Two-part Study to Evaluate the Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of BMS-986369 and to Explore the Effect of Food the Bioavailability of BMS-986369 in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-05-04